| Date | Target |
Transaction Type Value: $mlns |
Acquirer | Seller | ||
|---|---|---|---|---|---|---|
| 2022-12-13 |
GRI Bio
Life Science La Jolla, California www.gribio.com GRI Bio is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio’s therapies are designed to target the activity of NKT cells, which are key regulators earlier in the inflammatory cascade, to interrupt disease progression and restore the immune system to homeostasis. GRI Bio was founded in 2009 and is based in La Jolla, California. Advisor: Mintz Levin Cohn Ferris Glovsky and Popeo |
Merger |
GRI Bio
|
- | ||
| Deal Article Deal Link | ||||||
| 2022-11-14 |
Meridian Medical Technologies
Life Science St. Louis, Missouri www.meridianmeds.com Meridian Medical Technologies designs, develops, manufactures and supplies on-the-scene emergency response treatments and health security solutions with a focus on complex drug-device combination products. Meridian Medical Technologies is based in St. Louis, Missouri. |
Merger |
Kindeva Drug Delivery
|
Altaris
|
||
| Deal Article Deal Link | ||||||
| 2022-11-08 |
Silverback Therapeutics
Life Science Seattle, Washington www.silverbacktx.com Silverback Therapeutics is a clinical-stage biopharmaceutical company, develops tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company's lead product candidate is SBT6050, which is in a Phase I/Ib clinical trial, a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody that targets tumors, such as breast, gastric, and non-small cell lung cancers. It also focuses on developing SBT6290, a product candidate that is in the preclinical stage, which is a TLR8 linker-payload conjugated to a monoclonal antibody that targets Nectin4, which is expressed in bladder, triple-negative breast, head and neck, and non-small cell lung cancers. Silverback Therapeutics was founded in 2016 and is based in Seattle, Washington. Advisors: Cooley , Leerink Partners |
Merger |
ARS Pharmaceuticals
|
- | ||
| Deal Link | ||||||
| 2022-10-19 |
Advaxis
Life Science Monmouth Junction, New Jersey www.advaxis.com Advaxis is a clinical-stage biotechnology company developing multiple cancer immunotherapies based on its proprietary Lm-LLO platform technology. Advaxis was incorporated in 2002 and is headquartered in Monmouth Junction, New Jersey. |
Merger |
Ayala
|
- | ||
| Deal Article Deal Link | ||||||
| 2022-10-13 |
Imara
Life Science Boston, Massachusetts www.imaratx.com Imara develops novel therapeutics for people living with sickle cell disease and other hemoglobinopathies. Sickle cell disease is a rare, genetic blood disease that causes red blood cells to sickle and become damaged, activating immune cells and blocking blood flow in capillaries, injuring many organs and causing daily pain. Imara is developing IMR-687, a highly selective, potent small-molecule inhibitor of phosphodiesterase-9 (PDE9i), to treat patients with sickle cell disease. Imara was formed in 2016 and is based in Boston, Massachusetts. Advisors: Wilmer Cutler Pickering Hale and Dorr , Leerink Partners |
Merger |
Enliven Therapeutics
|
- | ||
| Deal Article Deal Link | ||||||
| 2022-07-19 |
Addmedica
Life Science Neuilly sur Seine, France www.addmedica.com Addmedica is a pharma company focused on developing and marketing medical products for rare diseases and niche markets. Addmedica is based in Neuilly sur Seine, France. |
Merger |
Theravia
|
Merieux Equity Partners
|
||
| 2022-07-19 |
Laboratoires CTRS
Life Science Boulogne-Billancourt, France www.ctrs.fr Laboratoires CTRS is a French pharmaceutical company focused on developing and marketing drugs for rare diseases and with a strong and growing international presence. Its main areas of expertise are Hereditary metabolic diseases and Oncology-haematology-immunology. Laboratoires CTRS was founded in 2002 and is based in Boulogne-Billancourt, France. |
Merger |
Theravia
|
Merieux Equity Partners
|
||
| 2022-07-14 |
Ganse Apothecary
Life Science Lancaster, Pennsylvania www.ganseapothecary.com Ganse Apothecary is a URAC accredited specialty, long-term care, and retail pharmacy that provides pharmacy services to individuals with serious and persistent mental illness, substance use disorders, and intellectual and developmental disabilities, the organizations that support them, and to the general public as well. Ganse Apothecary is based in Lancaster, Pennsylvania. Advisors: Troutman Pepper Hamilton Sanders , Provident Healthcare Partners |
Merger |
Altruix
|
- | ||
| Deal Article Deal Link | ||||||
| 2022-05-09 |
Ambi Pack
Life Science Hendrik-Ido-Ambacht, Netherlands www.ambipack.com Ambi Pack is a COMO in food supplements and medical devices. Ambi Pack was founded in 1998 and is based in Hendrik-Ido-Ambacht, Netherlands. |
Merger |
Naturacare
|
- | ||
| 2022-05-01 |
Strapharm
Life Science Saint-Hilaire-de-Loulay, France www.strapharm.fr Strapharm is a contract development and manufacturing company for food supplements. The company supplies major food supplement brands and large retailers in France and internationally. Strapharm covers the full range of food and dietary supplements and has significant expertise in products for supporting immunity, supporting sports performance and the health and vitality of pets. Strapharm was founded in 1987 and is based in France. |
Merger |
Naturacare
|
M80 Partners
|
||
| 2022-04-27 |
Cend Therapeutics
Life Science San Diego, California www.cendrx.com Cend Therapeutics is a privately held, clinical-stage biotechnology company focused on a novel approach to enable more effective treatments for solid tumor cancers. Cend Therapeutics is based in San Diego, California. |
Merger |
Lisata Therapeutics
|
- | ||
| Deal Article Deal Link | ||||||
| 2022-04-21 |
GeneProof
Life Science Brno, Czech Republic www.geneproof.com GeneProof is a molecular diagnostics company. GeneProof is a producer of PCR reagents and distributes its portfolio of more than 70 CE-marked molecular diagnostic tests and instruments throughout Europe, Africa, the Middle East, and South America. GeneProof was founded in 2005 and is based in Brno, Czech Republic. |
Merger |
NuvinkaDx
|
- | ||
| Deal Article Deal Link | ||||||
| 2022-04-18 |
Lygos
Life Science Berkeley, California www.lygos.com Lygos is a vertically integrated biotechnology provider of sustainable specialty ingredients. The company has created a biological engineering platform focused on the sustainable production of organic acid bio-monomers. Its bio-based ingredients offer alternatives to traditional industrial suppliers, enabling customers to create better, environmentally safer products. Lygos was formed in 2011 and is based in Berkeley, California. Advisor: Orrick |
Merger |
Flexible Solutions
|
- | ||
| Deal Article Deal Link | ||||||
| 2022-04-07 |
Novasep
Life Science Lyon, France www.novasep.com Novasep provides cost-effective solutions for the sustainable production of molecules for the life sciences. Novasep offers a comprehensive range of services including process development, turnkey purification systems and contract manufacturing. The company specializes in challenging active molecules for pharmaceutical, biopharmaceutical, fine chemical, food and functional ingredients, as well as fermentation and chemical commodities industries. Novasep is based in Lyon, France. |
Merger |
Axplora
|
Azulis Capital
Rivean Capital
|
||
| Deal Article Deal Link | ||||||
| 2022-01-27 |
Wise Pharmacy
Life Science Littleton, Colorado www.wisepharmacy.com Wise Pharmacy provides custom compounded medications for patients and physicians, based in Littleton, Colorado. |
Merger |
Pencol Pharmacy
|
- | ||
| Deal Article Deal Link | ||||||
| 2022-01-27 |
Convex Pharmacy
Life Science Orland Park, Illinois Convex Pharmacy provides custom compounded medications for patients and physicians nationwide, based in Orland Park, Illinois. |
Merger |
Everwell
|
- | ||
| Deal Article Deal Link | ||||||
| Avg |
$0.0
0.0x EBITDA 0.0x REVENUE |
|||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr was built to simplify the process of tracking who’s buying, selling, and what deals are happening across the private markets.
Behind every transaction is an opportunity, and Mergr gives professionals access to thousands of M&A deals, along with the investors, buyers, and sellers behind them.
The platform is powerful but easy to use — so you can quickly surface relevant transactions and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.
